What smart money is saying about Harrow, Inc.
HROW
No fund has written a full thesis on Harrow, Inc. in our archive, but 2 fund letters report a position in it — most recently Buffalo funds High Yield Fund in June 2026.
Get an email when a fund writes about it
2
Reported positions
0
Bought
0
Sold
2
Letters
Position history
Between Q1 2026 and Q2 2026, 2 fund letters reported a position in Harrow, Inc., with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 0 | 0 |
| Q1 2026 | 1 | 0 | 0 | 0 |
Fund activity · 2 positions
- June 2026
“TOP 10 HOLDINGS (%)* Amneal Pharmaceuticals, LLC (Term Loan, 8/1/23) 2.27 Harrow, Inc. (8.625% 9/15/30) 2.14 Grupo Aeromexico (8.625%, 11/15/31) 2.04”
Harrow, Inc. - March 2026
“TOP 10 HOLDINGS (%)* Amneal Pharmaceuticals, LLC (Term Loan, 7/23/32) 2.26 Grupo Aeromexico (8.625%, 11/15/31) 2.14 Verde Purchaser, LLC (Term Loan, 11/17/30) 1.78 Ardonagh Group Finance, Ltd. (8.875%, 2/15/32) 1.71 Nexus Buyer, LLC (Term Loan, 7/31/31) 1.58 Saturn Oil & Gas Inc. (9.625%, 6/15/29) 1.53 Endo Finance Holdings, Inc. (Term Loan, 4/23/31) 1.47 Harrow, Inc. (8.625%, 9/15/30) 1.41 Northern Oil And Gas, Inc. (8.125%, 3/1/28)”
Harrow, Inc.
Read the letters behind these Harrow, Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger